Kyiv is an important industrial, scientific, educational, and cultural center in Eastern Europe. It is home to many high-tech industries, higher education institutions, and historical landmarks. The …

Ukraine agrees to 30-day ceasefire if Russia abides by it, Kyiv says. Kyiv is ready to accept Washington's proposal to immediately implement a temporary, 30-day ceasefire which can be …

Higher education increases our ability to approach situations with reason, empathy and creativity. It is a powerful force against prejudice and fear. We have an opportunity to emerge from this …

Kyiv Post debunks The Telegraph’s report on Ukraine’s battlefield tactics, exposing inaccuracies, misleading claims, and questionable sources saying Ukraine ignored NATO training and …

KYB has you covered with shocks that restore performance and performance upgrade shock absorbers and struts for trucks. This is why we do it! KYB TV is a series of short videos …

KYV-101 is a novel, fully human CD19 CAR T-cell therapy for use in B cell-driven autoimmune diseases such as lupus nephritis, a serious complication of lupus.

Find the latest Kyverna Therapeutics, Inc. (KYTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

2024年1月5日 · The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics ‘ cell-based therapy candidate KYV-101 in people with treatment …

Kyverna is the exclusive worldwide licensee of a next-generation CAR T construct targeting CD19 for use in autologous (KYV-101 and KYV-102) and allogeneic (KYV-201) cell therapies for B …

Our mission is to liberate autoimmune patients through the curative potential of cell therapy. Kyverna is pioneering a durable disease-clearing approach aiming for deep B cell depletion, …